Haloperidol Prodes

Haloperidol Prodes is a prescription medication that contains the active ingredient haloperidol. The product is marketed in the European Union and is administered orally, although the specific dosage form and strength are not disclosed. Haloperidol belongs to the butyrophenone class of antipsychotics and works primarily as a dopamine D2 receptor antagonist, used in the management of various psychiatric conditions.

Haloperidol Prodes is indicated for several psychiatric disorders where dopamine blockade is beneficial. It is prescribed by healthcare professionals based on individual patient assessment.

- Treatment of schizophrenia, including maintenance therapy. - Management of acute psychotic episodes. - Control of manic episodes associated with bipolar disorder. - Reduction of symptoms in Tourette syndrome. - Adjunctive therapy for severe agitation or aggression.

Haloperidol Prodes may cause a range of side effects, varying in frequency and severity.

Common: - Drowsiness or sedation. - Extrapyramidal symptoms such as tremor or rigidity. - Dry mouth. - Constipation. - Blurred vision. - Weight gain.

Serious: - Neuroleptic malignant syndrome. - Tardive dyskinesia. - Severe hypotension. - Cardiac arrhythmias (QT prolongation). - Hyperprolactinemia leading to hormonal disturbances. - Severe allergic reactions (e.g., rash, angioedema).

Before initiating Haloperidol Prodes, clinicians should evaluate patient history and monitor for potential risks.

- Assess for cardiovascular disease, especially QT prolongation risk. - Monitor for movement disorders, particularly with long‑term use. - Use cautiously in patients with a history of seizures. - Evaluate liver and kidney function periodically. - Discuss potential pregnancy and lactation considerations with women of childbearing age. - Educate patients about signs of neuroleptic malignant syndrome and advise immediate medical attention if they occur.

Haloperidol Prodes can interact with several medications, influencing its efficacy or safety profile.

Avoid: - Other dopamine antagonists or antipsychotics, which may increase extrapyramidal side effects. - Medications that prolong the QT interval (e.g., certain antiarrhythmics, macrolide antibiotics). - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can raise haloperidol plasma levels.

Use with caution: - CNS depressants such as benzodiazepines or opioids, which may enhance sedation. - Anticholinergic agents, which can mask early signs of extrapyramidal symptoms. - Antihypertensive drugs, as haloperidol may cause orthostatic hypotension. - Lithium, due to potential additive neurotoxic effects.